June 6, 2020

The Niche

Knoepfler lab stem cell blog

Search Results for: trump

3 min read

Would you believe in a stem cell miracle? Sometimes the mainstream media stumbles in its coverage of the stem cell world and a recent CNN puff piece on a patient of stem cell clinic Celltex is a prime example of just how extreme this can get. The CNN piece focuses on a Celltex patient who self-reports perceived big improvement after receiving the non-FDA approved offerings of the Texas stem cell clinic. Celltex is most famous for their number one customer and supporter Rick Perry, former Governor …Read More

2 min read

The first ten days of Donald Trump’s presidency have been just as extreme as many had feared including those of us in the scientific community, but the early reactions of scientists to fight Trump’s agenda have been encouraging. We’ve collectively been sparked to “get out of the lab” and do something about it. There are many things one can do as a scientist to oppose Trump’s extremism. I wrote a post on December 2 about how scientists can try to deal with the new Trump …Read More

2 min read

Dear FDA, The stem cell clinic clock is ticking on you. Before the Trump administration rolls in to possibly tie your hands on many important areas of oversight including stem cell clinics, you should take bold action now. Your CBER branch has been preternaturally quiet on taking actual regulatory actions on stem cell clinics for several years now even though there about 600 such clinics in the U.S. operating without any FDA approvals putting thousands of patients and the stem cell field at risk. …Read More

2 min read

Since Donald Trump was elected our new president the scientific community has tried to adjust to this new reality or at least absorb the shock that many felt. Responses from scientists range from “not my president” to “maybe it won’t be so bad”. Mostly it seems people are stressed about an uncertain future for science and our country overall. If you just look at a science-related Twitter feed you can feel the palpable tension in the air. How should we scientists deal with this …Read More

1 min read

Will Trump trump the FDA? Our President-elect recently released his health care policy agenda and it looks like the FDA is a target in terms of reducing oversight. Over at the Washington Post, Carolyn Johnson has a nice article on this development. One point in the agenda in particular has caught people’s attention as potentially the key indicator of what is to come for regulatory oversight of biomedical products: “Reform the Food and Drug Administration, to put greater focus on the need of patients for new …Read More